Cagynol

Medicinal product

(Invented) name

Cagynol

Active substance (s)

Sertakonazolo nitratas

Strength

300 mg

Pharmaceutical form

ovulė

Route (s) of administration

vartoti į makštį

Purpose for use

suaugusiesiems

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AF19, Sertaconazole

Marketing authorisation holder

UAB Orivas, Lietuva

Date of authorisation

2022-05-30

Date of renewal

Documents

4955_Cagynol.docx

LT_H_164_DC_PAR_Cagynol_summaryLT apzvalga.pdf

4955_pakuotes lapelis_2022-05-30.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

LT/H/0164/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Ovulėje yra:	1 vnt.
Sertakonazolo nitratas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108735	94841	1094841	lizdinė plokštelė	N1		Nereceptinis	LT/1/22/4955/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-05-30	Registruotas